These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7042178)

  • 1. Metrizamide as contrast medium in endoscopic retrograde cholangio-pancreatography.
    Hamilton I; Lintott DJ; Rothwell J; Axon AT
    Clin Radiol; 1982 May; 33(3):293-5. PubMed ID: 7042178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iopamidol as contrast medium in endoscopic retrograde pancreatography: a prospective randomised comparison with diatrizoate.
    O'Connor HJ; Ellis WR; Manning AP; Lintott DJ; McMahon MJ; Axon AT
    Endoscopy; 1988 Sep; 20(5):244-7. PubMed ID: 3168937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised, prospective study comparing two contrast media in ERCP.
    Cunliffe WJ; Cobden I; Lavelle MI; Lendrum R; Tait NP; Venables CW
    Endoscopy; 1987 Sep; 19(5):201-2. PubMed ID: 3678161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute pancreatitis following endoscopic retrograde cholangiopancreatography.
    Hamilton I; Lintott DJ; Rothwell J; Axon AT
    Clin Radiol; 1983 Sep; 34(5):543-6. PubMed ID: 6617085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Side effects of Urografin and Amipaque in hysterosalpingography. A randomized prospective study].
    Cold S; Hansen KF; Pedersen PR; Petersen J
    Ugeskr Laeger; 1983 Apr; 145(17):1304-6. PubMed ID: 6349068
    [No Abstract]   [Full Text] [Related]  

  • 6. ERCP-induced and non-ERCP-induced acute pancreatitis: Two distinct clinical entities with different outcomes in mild and severe form?
    Testoni PA; Vailati C; Giussani A; Notaristefano C; Mariani A
    Dig Liver Dis; 2010 Aug; 42(8):567-70. PubMed ID: 20018574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immediate effects of retrograde pancreatography on the pancreas.
    Kivisaari L; Alitalo I
    Eur J Radiol; 1984 Feb; 4(1):58-60. PubMed ID: 6723675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iopentol (Imagopaque 250) compared with diatrizoate (Urografin 219) in endoscopic retrograde cholangio-pancreatography (ERCP). A clinical trial assessing safety (adverse events and S-pancreatic iso-amylase) and diagnostic information (VAS).
    Kruse A; Brock A; Rodenberg J; Nowakowska-Duawa E; Bjartveit K
    Eur Radiol; 1997; 7 Suppl 4():S131-4. PubMed ID: 9204355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arthrography of the knee joint with amipaque.
    Johansen JG; Lilleas FG; Nordshus T
    Acta Radiol Diagn (Stockh); 1977 Sep; 18(5):523-8. PubMed ID: 337758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency of hyperamylasemia after ERCP with diatrizoate and iohexol.
    Mäkelä P; Dean PB
    Eur J Radiol; 1986 Nov; 6(4):303-4. PubMed ID: 2431908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental pancreatography: a comparison of three contrast media.
    Saari A; Kivisaari L; Standertskjöld-Nordenstam CG; Brackett K; Schröder T
    Scand J Gastroenterol; 1988 Jan; 23(1):53-8. PubMed ID: 3344398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trial of low versus high osmolar contrast media in endoscopic retrograde cholangiopancreatography.
    Banerjee AK; Grainger SL; Thompson RP
    Br J Clin Pract; 1990 Nov; 44(11):445-7. PubMed ID: 2282293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of contrast agents for endoscopic retrograde pancreatography.
    Barkin JS; Casal GL; Reiner DK; Goldberg RI; Phillips RS; Kaplan S
    Am J Gastroenterol; 1991 Oct; 86(10):1437-41. PubMed ID: 1928034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The probability of pancreatitis after pancreatic parenchymatography with a non-ionic contrast medium. A sequentially designed clinical trial.
    Løtveit T; Larsen S; Grønseth K; Osnes M
    Scand J Gastroenterol; 1987 Jan; 22(1):111-6. PubMed ID: 3551047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography performed during the same anesthesia session].
    Duchmann JC; Benkirane A; Herve E; Barbare JC; Latrive JP; Messerschmitt C
    Gastroenterol Clin Biol; 1999 Oct; 23(10):1028-32. PubMed ID: 10592874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of iohexol versus amidotrizoate in endoscopic retrograde pancreatography.
    Jensen AR; Malchow-Møller A; Matzen P; Larsen JE; Møller F; Andersen JR; Magid E
    Scand J Gastroenterol; 1985 Jan; 20(1):83-6. PubMed ID: 2581308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anatomical and radiological aspects of retrograde pancreatography in chronic pancreatitis (author's transl)].
    Camellini U; Marconi G; Colla GC; Larini P; Labò PL
    Ateneo Parmense Acta Biomed; 1979; 50(4):229-38. PubMed ID: 555661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography.
    Banerjee A
    Am J Gastroenterol; 1992 May; 87(5):683-4; author reply 684-5. PubMed ID: 1595671
    [No Abstract]   [Full Text] [Related]  

  • 19. Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification.
    Cheon YK; Cho KB; Watkins JL; McHenry L; Fogel EL; Sherman S; Lehman GA
    Gastrointest Endosc; 2007 Mar; 65(3):385-93. PubMed ID: 17321236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic retrograde cholangio-pancreatography in pancreatitis with persistent or recurrent pain.
    Winstanley PA; Manning AP; Lintott DJ; Axon AT
    Int J Pancreatol; 1986 Dec; 1(5-6):407-12. PubMed ID: 3681032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.